WESTLAKE VILLAGE, Calif., Sept. 28, 2021 (GLOBE NEWSWIRE) — MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for patients with endocrine and orphan lung diseases, announced today that it will be participating at the Lytham Partners Fall 2021 Investor Conference on Tuesday, October 5, 2021 at 11:45 am (ET). Presenting from the Company will be its Chief Executive Officer, Michael Castagna, PharmD.
Interested parties can access a link to the live webcast of the presentations from the Events & Presentations section of the Company’s website at https://investors.mannkindcorp.com/events-and-presentations. The webcast replay may be accessed at the same location for 14 days following the live presentation.
About MannKind Corporation
MannKind Corporation (Nasdaq: MNKD) focuses on the development and commercialization of inhaled therapeutic products for patients with endocrine and orphan lung diseases. MannKind is currently commercializing Afrezza® (insulin human) Inhalation Powder, the Company’s first FDA-approved product and the only inhaled ultra rapid-acting mealtime insulin in the United States, where it is available by prescription from pharmacies nationwide. Afrezza is also available by prescription in Brazil, where it is commercialized by the Company’s partner Biomm SA. MannKind was established in 1991, and is headquartered in Westlake Village, Calif., with a manufacturing and R&D facility based in Danbury, Conn. The Company also employs field sales and medical representatives across the U.S. Please visit mannkindcorp.com to learn more.
Contact:
Rose Alinaya, Investor Relations
(818) 661-5000
Email: ir@mannkindcorp.com
Vancouver, British Columbia--(Newsfile Corp. - March 28, 2024) - CENTR Brands Corp. (CSE: CNTR) (FSE:…
BOCA RATON, FL / ACCESSWIRE / March 28, 2024 / Haven Health Care Services, a…
BOULDER, CO / ACCESSWIRE / March 28, 2024 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global…
JACKSONVILLE, FL / ACCESSWIRE / March 28, 2024 / LFTD Partners Inc. ("LFTD Partners" or…
Unify Medical, Inc., a privately held, smart surgical visualization technology company, announced the appointment of…
Texas-based specialty practice chooses eClinicalWorks Cloud EHR to increase automation, streamline workflows, and enhance patient…